Medicines
Shortlist up to four to read them side by side.
704 medicine recalls FDA’s Enforcement Report published in 2026, the newest year, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
704of 704 medicine recallsshown with your filters
The list
- Medicine recall Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60… CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a… Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportOhiothe one state its words name PublishedJul 8, 2026ClassClass IIStatusOngoingWhereOhio
- Medicine recall Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% Lack of Assurance of Sterility Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Lidocaine HCl Injection USP, 1% Lack of Assurance of Sterility Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine… Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1% Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall vite20 Antifungal Cream CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall TERPENICOL Antifungal Solution, (Undecylenic CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Gemcitabine Injection, 1 g per 26.3 mL Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment. Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1… CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing. Class IIFDA’s classJul 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS Subpotent Drug Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Fenofibrate Capsules, USP 200 mg CGMP Deviations Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Corlanor (ivabradine) tablets, 5 mg Presence of Foreign Substance. Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Sensipar (cinacalcet) Tablets, 30mg, 30-count bottles CGMP Deviations Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles CGMP Deviations Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles Presence of Foreign Substance. Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles CGMP Deviations Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx#… Incorrect product formulation: bag did not contain copper and famotidine per label. Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportMassachusettsthe one state its words name PublishedJul 1, 2026ClassClass IIStatusOngoingWhereMassachusetts
- Medicine recall hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL Presence of foreign substance Class IIIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall PReye Vitamin See Antioxidant Preservative Free Eye Drops Lack of Assurance of Sterility Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportColoradothe one state its words name PublishedJul 1, 2026ClassClass IIStatusOngoingWhereColorado
- Medicine recall BD ChloraPrep Clear Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area. Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall BD ChloraPrep FREPP Clear Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area. Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall BD ChloraPrep Clear Non-Sterility: Due to presence of Aspergillus penicillioides. FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall BD ChloraPrep FREPP Clear,(2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) 1.5 mL… Non-Sterility: Due to presence of Aspergillus penicillioides. FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall Lacosamide Tablets, USP, C V, 100mg Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg. Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Povi-One, 10% Povidone-Iodine Oral Antiseptic sub potency Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Perampanel CIII Tablets, 6mg Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets. Class IIFDA’s classJul 1, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 1, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg,… Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities. Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY FLAVOR, 25 Grams Activated Charcoal Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY FLAVOR, 50 Grams Activated Charcoal Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 25 Grams Activated Charcoal Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 50 Grams Activated Charcoal Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Vasopressin 2 Units/2 mL Subpotent Drug Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Aripiprazole Tablets USP Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton Crystallization; identified as Buprenorphine free base Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Pearson Quality Topical Anesthetic Gel Defective container:may contain bottles with incomplete seals Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Quala Dental Products, Topical Anesthetic Gel, 20 % Benzocaine, Strawberry Flavor Net Contents: 1 oz Defective container:may contain bottles with incomplete seals Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall DHP Topical Anesthetic Gel, Benzocaine 20%, Strawberry Flavor, 1 oz. Defective container:may contain bottles with incomplete seals Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Burkhart topical anesthetic gel, benzocaine 20 %, Strawberry Flavor, 1 oz Defective container:may contain bottles with incomplete seals Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Dental City TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, Strawberry Flavor, 1 OZ Defective container:may contain bottles with incomplete seals Class IIFDA’s classJun 24, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 24, 2026ClassClass IIStatusOngoingWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.